Alanyl-glutamine resolves lipopolysaccharide-induced lung injury in mice by modulating the polarization of regulatory T cells and T helper 17 cells

Journal of Nutritional Biochemistry

Volumn 24, Issue 9, 2013, Pages 1555-1563

  Hou, Yu Chen ^a   Pai, Man Hui ^a   Liu, Jun Jen ^a   Yeh, Sung Ling ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Acute lung injury; Glutamine; Lipopolysaccharide; Regulatory T cells; T helper 17 cells

Indexed keywords

ALANYLGLUTAMINE; INTERLEUKIN 2; LIPOPOLYSACCHARIDE;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL POLARITY; CONTROLLED STUDY; DISEASE SEVERITY; GENE EXPRESSION; HISTOPATHOLOGY; LUNG FLUID; LUNG LAVAGE; LUNG PARENCHYMA; LUNG WEIGHT; MOUSE; NEUTROPHIL; NONHUMAN; PNEUMONIA; REGULATORY T LYMPHOCYTE; SINGLE DRUG DOSE; TH17 CELL; WEIGHT REDUCTION;

MUS;

EID: 84881553223     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.01.004     Document Type: Article

References (51)

1. Strieter R.M., Kunkel S.L., Keane M.P., Standiford T.J. Chemokines in lung injury: Thomas A. Neff lecture. Chest 1999, 116:103S-110S.
2. Abraham E. Neutrophils and acute lung injury. Crit Care Med 2003, 31:S195-S199.
3. Serhan C.N., Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol 2005, 6:1191-1197.
4. Moret I., Lorenzo M.J., Sarria B., Cases E., Morcillo E., Perpina M., et al. Increased lung neutrophil apoptosis and inflammation resolution in nonresponding pneumonia. Eur Respir J 2011, 38:1158-1164.
5. Kotecha S., Mildner R.J., Prince L.R., Vyas J.R., Currie A.E., Lawson R.A., et al. The role of neutrophil apoptosis in the resolution of acute lung injury in newborn infants. Thorax 2003, 58:961-967.
6. Wu C.L., Lin L.Y., Yeh H.M., Chan M.C., Yang C.H., Hsueh C.M. Delay of LPS-induced acute lung injury resolution by soluble immune complexes is neutrophil dependent. Shock 2009, 32:276-285.
7. D'Alessio F.R., Tsushima K., Aggarwal N.R., West E.E., Willett M.H., Britos M.F., et al. CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. J Clin Invest 2009, 119:2898-2913.
8. Stockinger B., Veldhoen M., Martin B. Th17 T cells: linking innate and adaptive immunity. Semin Immunol 2007, 19:353-361.
9. Guarda G., Dostert C., Staehli F., Cabalzar K., Castillo R., Tardivel A., et al. T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes. Nature 2009, 460:269-273.
10. Antunes I., Kassiotis G. Suppression of innate immune pathology by regulatory T cells during influenza A virus infection of immunodeficient mice. J Virol 2010, 84:12564-12575.
11. Holley M.M., Kielian T. Th1 and Th17 cells regulate innate immune responses and bacterial clearance during central nervous system infection. J Immunol 2012, 188:1360-1370.
12. Afzali B., Lombardi G., Lechler R.I., Lord G.M. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 2007, 148:32-46.
13. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005, 6:345-352.
14. Vignali D.A., Collison L.W., Workman C.J. How regulatory T cells work. Nat Rev Immunol 2008, 8:523-532.
15. Sakaguchi S., Yamaguchi T., Nomura T., Ono M. Regulatory T cells and immune tolerance. Cell 2008, 133:775-787.
16. Miyamoto M., Prause O., Sjostrand M., Laan M., Lotvall J., Linden A. Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J Immunol 2003, 170:4665-4672.
17. Laan M., Cui Z.H., Hoshino H., Lotvall J., Sjostrand M., Gruenert D.C., et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 1999, 162:2347-2352.
18. Mi S., Li Z., Yang H.Z., Liu H., Wang J.P., Ma Y.G., et al. Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and -independent mechanisms. J Immunol 2011, 187:3003-3014.
19. De Luca A., Rindi L., Celi A., Melosini L., Paggiaro P., Nelli L.C., et al. Intracellular detection of interleukin 17 and other cytokines in human bronchoalveolar lavage fluid: a first assessment. Immunol Lett 2012, 141:204-209.
20. Andrews F.J., Griffiths R.D. Glutamine: essential for immune nutrition in the critically ill. Br J Nutr 2002, 87:S3-S8.
21. Fleming S.E., Fitch M.D., DeVries S., Liu M.L., Kight C. Nutrient utilization by cells isolated from rat jejunum, cecum and colon. J Nutr 1991, 121:869-878.
22. Wischmeyer P.E. Glutamine: mode of action in critical illness. Crit Care Med 2007, 35:S541-S544.
23. Kwon W.Y., Suh G.J., Kim K.S., Jo Y.H., Lee J.H., Kim K., et al. Glutamine attenuates acute lung injury by inhibition of high mobility group box protein-1 expression during sepsis. Br J Nutr 2010, 103:890-898.
24. Nakamura T., Yamakawa M., Maeda J., Mimura Y., Yamada H., Ogawa T., et al. Effect of glutamine on acute lung injury in rats with endotoxemia. Clin Nutr 1997, 16:79-83.
25. Singleton K.D., Beckey V.E., Wischmeyer P.E. Glutamine prevents activation of NF-kappaB and stress kinase pathways, attenuates inflammatory cytokine release, and prevents acute respiratory distress syndrome (ARDS) following sepsis. Shock 2005, 24:583-589.
26. Singleton K.D., Wischmeyer P.E. Glutamine attenuates inflammation and NF-kappaB activation via Cullin-1 deneddylation. Biochem Biophys Res Commun 2008, 373:445-449.
27. Wischmeyer P.E., Kahana M., Wolfson R., Ren H., Musch M.M., Chang E.B. Glutamine induces heat shock protein and protects against endotoxin shock in the rat. J Appl Physiol 2001, 90:2403-2410.
28. Chu C.C., Hou Y.C., Pai M.H., Chao C.J., Yeh S.L. Pretreatment with alanyl-glutamine suppresses T-helper-cell-associated cytokine expression and reduces inflammatory responses in mice with acute DSS-induced colitis. J Nutr Biochem 2012, 23:1092-1099.
29. Yeh C.L., Hsu C.S., Yeh S.L., Chen W.J. Dietary glutamine supplementation modulates Th1/Th2 cytokine and interleukin-6 expressions in septic mice. Cytokine 2005, 31:329-334.
30. Brigham K.L., Meyrick B. Endotoxin and lung injury. Am Rev Respir Dis 1986, 133:913-927.
31. Kitamura Y., Hashimoto S., Mizuta N., Kobayashi A., Kooguchi K., Fujiwara I., et al. Fas/FasL-dependent apoptosis of alveolar cells after lipopolysaccharide-induced lung injury in mice. Am J Respir Crit Care Med 2001, 163:762-769.
32. Novak F., Heyland D.K., Avenell A., Drover J.W., Su X. Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med 2002, 30:2022-2029.
33. Ward E., Picton S., Reid U., Thomas D., Gardener C., Smith M., et al. Oral glutamine in paediatric oncology patients: a dose finding study. Eur J Clin Nutr 2003, 57:31-36.
34. Galera S.C., Fechine F.V., Teixeira M.J., Coelho Z.C., de Vasconcelos R.C., de Vasconcelos P.R. The safety of oral use of L-glutamine in middle-aged and elderly individuals. Nutrition 2010, 26:375-381.
35. Vaschetto R., Kuiper J.W., Chiang S.R., Haitsma J.J., Juco J.W., Uhlig S., et al. Inhibition of poly(adenosine diphosphate-ribose) polymerase attenuates ventilator-induced lung injury. Anesthesiology 2008, 108:261-268.
36. Li P., Yin Y.L., Li D., Kim S.W., Wu G. Amino acids and immune function. Br J Nutr 2007, 98:237-252.
37. Scheffold A., Murphy K.M., Hofer T. Competition for cytokines: T(reg) cells take all. Nat Immunol 2007, 8:1285-1287.
38. Kimura A., Kishimoto T. IL-6: regulator of Treg/Th17 balance. Eur J Immunol 2010, 40:1830-1835.
39. Zheng S.G., Wang J., Wang P., Gray J.D., Horwitz D.A. IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J Immunol 2007, 178:2018-2027.
40. Chen Q., Kim Y.C., Laurence A., Punkosdy G.A., Shevach E.M. IL-2 controls the stability of Foxp3 expression in TGF-beta-induced Foxp3+ T cells in vivo. J Immunol 2011, 186:6329-6337.
41. Laurence A., Tato C.M., Davidson T.S., Kanno Y., Chen Z., Yao Z., et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 2007, 26:371-381.
42. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
43. Korn T., Mitsdoerffer M., Croxford A.L., Awasthi A., Dardalhon V.A., Galileos G., et al. IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells. Proc Natl Acad Sci 2008, 105:18460-18465.
44. Yaqoob P., Calder P.C. Glutamine requirement of proliferating T lymphocytes. Nutrition 1997, 13:646-651.
45. Costa V.S., Mattana T.C., da Silva M.E. Unregulated IL-23/IL-17 immune response in autoimmune diseases. Diabetes Res Clin Pract 2010, 88:222-226.
46. Zenewicz L.A., Flavell R.A. Recent advances in IL-22 biology. Int Immunol 2011, 23:159-163.
47. Sonnenberg G.F., Nair M.G., Kirn T.J., Zaph C., Fouser L.A., Artis D. Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A. J Exp Med 2010, 207:1293-1305.
48. Austgen T.R., Chen M.K., Salloum R.M., Souba W.W. Glutamine metabolism by the endotoxin-injured lung. J Trauma 1991, 31:1068-1074. [discussion 1074-5].
49. Hou Y.C., Pai M.H., Chiu W.C., Hu Y.M., Yeh S.L. Effects of dietary glutamine supplementation on lung injury induced by lipopolysaccharide administration. Am J Physiol Lung Cell Mol Physiol 2009, 296:L288-L295.
50. Pithon-Curi T.C., Levada A.C., Lopes L.R., Doi S.Q., Curi R. Glutamine plays a role in superoxide production and the expression of p47phox, p22phox and gp91phox in rat neutrophils. Clin Sci (Lond) 2002, 103:403-408.
51. Pithon-Curi T.C., Schumacher R.I., Freitas J.J., Lagranha C., Newsholme P., Palanch A.C., et al. Glutamine delays spontaneous apoptosis in neutrophils. Am J Physiol Cell Physiol 2003, 284:C1355-C1361.